CHEMODNERVATION FOR CERVICAL DYSTONIA: A CLINICAL REVIEW

被引:1
|
作者
Ameer, Muhammad Atif [1 ]
Bhatti, Danish [1 ]
机构
[1] Univ Nebraska Med Ctr, Dept Neurol Sci, Omaha, NE 68198 USA
来源
关键词
Cervical Dystonia; Torticollis; Chemodenervation; Nerve Block; Botulinum Toxins; Movement Disorders; BOTULINUM TOXIN INJECTION; SPASMODIC TORTICOLLIS; DOUBLE-BLIND; AMERICAN-ACADEMY; NEUROTOXIN; EFFICACY; LONG; SAFETY; MANAGEMENT; TETANUS;
D O I
10.35845/kmuj.2020.20478
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cervical dystonia (CD) is a focal dystonia characterized by involuntary contractions of neck muscles that result in patterned movements and abnormal postures of the head and neck that have a directional quality. CD is the most common form of dystonia presenting to the movement disorders clinic. Botulinum toxin is an effective treatment for cervical dystonia. It has become the first-line treatment for cervical dystonia with a satisfactory relief of symptoms reported in more than 80% of the cases. Multiple small and large scale studies proven that fact and provided Class-A evidence for the benefit. However, 20% of the patients discontinue treatment due to adverse effects, treatment failure and other reasons. With the proper knowledge of toxins and the anatomy of the neck, much better results can be achieved with fewer and self-limiting adverse effects as compared to other modalities. However, the expert consensus recommendations are lacking to guide clinicians for optimal use of botulinum toxin for cervical dystonias. This paper discusses the different available treatments, botulinum injection techniques and the adverse effects involved with the procedure.
引用
收藏
页码:253 / 258
页数:6
相关论文
共 50 条
  • [1] Clinical characteristics in patients with cervical dystonia
    Demirkiran, M.
    Demir, T.
    Kafadar, M.
    MOVEMENT DISORDERS, 2014, 29 : S495 - S495
  • [2] Clinical perspectives of physical therapy for cervical dystonia and hand dystonia
    Bleton, J-P
    JOURNAL OF NEURAL TRANSMISSION, 2013, 120 (07) : 1138 - 1139
  • [3] IDIOPATHIC CERVICAL DYSTONIA - CLINICAL CHARACTERISTICS
    CHAN, J
    BRIN, MF
    FAHN, S
    MOVEMENT DISORDERS, 1991, 6 (02) : 119 - 126
  • [4] A Systematic Review of Cognition in Cervical Dystonia
    O'Connor, Sarah
    Hevey, David
    Burke, Tom
    Rafee, Shameer
    Pender, Niall
    O'Keeffe, Fiadhnait
    NEUROPSYCHOLOGY REVIEW, 2024, 34 (01) : 134 - 154
  • [5] A Systematic Review of Cognition in Cervical Dystonia
    Sarah O’Connor
    David Hevey
    Tom Burke
    Shameer Rafee
    Niall Pender
    Fiadhnait O’Keeffe
    Neuropsychology Review, 2024, 34 : 134 - 154
  • [6] Duration of botulinum toxin efficacy in cervical dystonia clinical trials: A scoping review
    Castagna, Anna
    Jinnah, Hyder A.
    Albanese, Alberto
    PARKINSONISM & RELATED DISORDERS, 2024, 125
  • [7] Duration of Botulinum Toxin Efficacy in Cervical Dystonia Clinical Trials: A Narrative Review
    Castagna, Anna
    Jinnah, Hyder A.
    Albanese, Alberto
    TOXICON, 2024, 237 : 17 - 18
  • [8] Cervical dystonia: Disease profile and clinical management
    Crowner, Beth E.
    PHYSICAL THERAPY, 2007, 87 (11): : 1511 - 1526
  • [9] Clinical characteristics of the geste antagoniste in cervical dystonia
    Müller, J
    Wissel, T
    Masuhr, F
    Ebersbach, G
    Wenning, GK
    Poewe, W
    JOURNAL OF NEUROLOGY, 2001, 248 (06) : 478 - 482
  • [10] Botulinum toxin in the clinical management of cervical dystonia
    Comella, CL
    NEUROLOGY, 2000, 55 (12) : S1 - S1